IPP Bureau
World’s first Whole Genome Sequencing study uncovers new and potential therapies
By IPP Bureau - November 12, 2021
The ground-breaking project, led by Genomics England and NHS England, was established in 2013 to sequence 100,000 whole genomes from NHS patients and their families
Ronapreve gets the green light from CHMP to treat non-hospitalised Covid-19 patients
By IPP Bureau - November 12, 2021
A final decision regarding the approval of Ronapreve is expected from the European Commission shortly
Jubilant Biosys expands Chemistry Innovation Research Centre
By IPP Bureau - November 12, 2021
The centre has an initial capacity of 500 FTEs
Sun Pharma to introduce molnupiravir in India
By IPP Bureau - November 12, 2021
The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India
Covaxin well tolerated with no safety concerns: Lancet
By IPP Bureau - November 12, 2021
Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%
Solara Active Pharma Sciences PAT slides to Rs 29.71 cr in Q2FY22
By IPP Bureau - November 12, 2021
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
J.B Chemicals & Pharmaceuticals PAT at Rs 98 cr. in Q2FY22
By IPP Bureau - November 12, 2021
J. B. Chemicals & Pharmaceuticals Limited (JBCPL), announced its financial results for the second quarter ended 30th September, 2021
Alembic Pharma PAT at Rs 169.29 cr. in Q2FY22
By IPP Bureau - November 11, 2021
The Board of Directors of Alembic Pharmaceuticals have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021.
Metropolis Healthcare PAT at Rs 58.26 cr in Q2FY22
By IPP Bureau - November 11, 2021
Metropolis Healthcare has reported consolidated financial results for the period ended September 30, 2021
Curadev Pharma partners with CMC Vellore for dengue research
By IPP Bureau - November 11, 2021
The company will provide the technical and financial resources to support the study
Hester Biosciences to acquire 50 % stake in Thrishool Exim, Tanzania
By IPP Bureau - November 11, 2021
The consideration for the acquisition is US $ 2.25 million
Sudeep Pharma ventures into nutrition
By IPP Bureau - November 11, 2021
Sudeep Nutrition will be a one-stop solution for food, beverage, nutraceuticals and nutritional product manufacturers
Clinical study shows ViroStop spray prevents Covid-19
By IPP Bureau - November 11, 2021
Evidence also shows better immune response to virus among users of spray
LifeCell Diagnostics expands newborn screening portfolio
By IPP Bureau - November 11, 2021
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
.png "Medtronic first to launch cryoballoon catheter in India")
Medtronic first to launch cryoballoon catheter in India
By IPP Bureau - November 10, 2021
Cryoballoon catheter ablation, a minimally invasive procedure, is one of the therapeutic modalities to manage Atrial fibrillation
